Features Screener Stocks Charts
Sign In Sign Up

LINCOLN Pharmaceuticals Income Statement

NSE:LINCOPH | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year LINCOPH income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 5.81B 6.23B
Cost of Revenue -2.78B -2.91B
Gross Profit 3.02B 3.32B
Sales, General & Admin -1.03B -1.12B
Operating Income 892.85M 885.94M
Profit Before Tax 1.22B 1.09B
Net Income 933.05M 823.46M
Diluted Shares 20.03M 20.03M
Diluted EPS 46.58 41.11

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025